Christopher Ung

Christopher Ung is the current Chief Scientific Business Officer at CellCarta. Christopher has also served as the Chief Business Officer at Christopher'stoGeneX and as the President & COO at Biomarker Laboratory. In addition, they have been an Advisory Board Member at STC Biologics and the COO, Vice President, Business Development & Licensing at Ligacept.

Ung has over 25 years of experience in business development, strategic planning, and product development in the biotech and pharmaceutical industries. Christopher has a proven track record in building successful companies and teams, and in developing and commercializing innovative products.

Christopher Ung received their MBA from the University of California, Los Angeles and their MSc in Chemistry from the University of California, Berkeley.

Their manager is Martin Leblanc, CEO. They are on a team with Todd Chermak - Chief Regulatory & Government Affairs Officer, Dirk Hendriks - SVP & CFO, Christopher'stoCarta & GeneCarta, and Anthony Mattacchione - Global Chief Financial Officer.